Xtant Medical Holdings

XTNT61

Penny Stock

$0.74arrow_drop_up0.33%$0.00

Penny Stock

XTNT61

$0.74

arrow_drop_up0.33%$0.00

Penny Stock

Performance History

Key Stats
Open	$0.74
Prev. Close	$0.74
EPS	-0.01
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$102.64M
PE Ratio	-

	LOW	HIGH
Day Range	0.74	0.76
52 Week Range	0.51	1.45

Ratios







EPS	-0.01

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Xtant Medical Holdings (XTNT)

Xtant Medical Holdings Inc. (XTNT) is a medical device company focused on the design, development, and commercialization of regenerative medicine products. Founded in 1994 and headquartered in Belgrade, Montana, Xtant Medical Holdings is dedicated to providing innovative solutions for patients and healthcare professionals. With a mission to enhance the quality of life for patients through science and innovation, Xtant Medical Holdings strives to improve clinical outcomes and drive value for its stakeholders.

As of the most recent market close, the stock price for Xtant Medical Holdings Inc. (XTNT) was $0.20 per share. Over the past year, the stock has shown a 52-week range between $0.03 and $1.45. The day's trading volume for XTNT was 500,000 shares. Xtant Medical Holdings Inc. has a market capitalization of $11.5 million. The company's price-to-earnings growth (PEG) ratio is currently unavailable.

Websitecall_made

Sector: Healthcare
Industry: Medical Devices
CEO: Mr. Sean E. Browne
Headquarters: Belgrade
Employees: 134
Exchange: NYSE

Keep an eye on Xtant Medical Holdings

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is the market capitalization of Xtant Medical Holdings (XTNT)?

Xtant Medical Holdings (XTNT) has a market capitalization of $102.65M. The average daily trading volume is 98.41K, indicating the stock's liquidity and investor engagement.

help

What is Xtant Medical Holdings 's (XTNT) price per share?

The current price per share for Xtant Medical Holdings (XTNT) is $0.74. The stock has seen a price change of $0 recently, indicating a 0.34% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Xtant Medical Holdings (XTNT)?

For Xtant Medical Holdings (XTNT), the 52-week high is $1.45, which is 95.29% from the current price. The 52-week low is $0.51, the current price is 45.59% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Xtant Medical Holdings (XTNT) a growth stock?

Xtant Medical Holdings (XTNT) has shown an average price growth of 0.41% over the past three years. It has received a score of 39 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Xtant Medical Holdings as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Xtant Medical Holdings (XTNT) stock price performance year to date (YTD)?

As of the latest data, Xtant Medical Holdings (XTNT) has a year-to-date price change of -38.64%. Over the past month, the stock has experienced a price change of 11.81%. Over the last three months, the change has been 18.42%. Over the past six months, the figure is -28.61%. Looking at a longer horizon, the five-year price change stands at -72.5%.

help

Is Xtant Medical Holdings (XTNT) a profitable company?

Xtant Medical Holdings (XTNT) has a net income of $660K, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 60.75% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -9.84% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $91.3M, with a revenue growth rate of 57.5%, providing insight into the company's sales performance and growth. The gross profit is $55.47M. Operating income is noted at -$10.16M. Furthermore, the EBITDA is -$9.7M.